Filing Details
- Accession Number:
- 0001144204-17-044724
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-23 15:22:51
- Reporting Period:
- 2017-08-23
- Accepted Time:
- 2017-08-23 14:22:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1137883 | Brainstorm Cell Therapeutics Inc. | BCLI | Biological Products, (No Disgnostic Substances) (2836) | 207273918 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1608814 | Uri Yablonka | C/O Brainstorm Cell Therapeutics, Inc. 3 University Plaza Drive, Suite 320 Hackensack NJ 07601 | Evp & Chief Business Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-23 | 2,000 | $3.98 | 7,543 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
